Company / Operating Income
Kura Oncology, Inc. Operating Income History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$303.6M
FY2025
5-year range
-$303.6M / -$139.9M
FY2022-FY2025
Trend
-57.2%
vs FY2024
Sector context
#165 of 204
Health Care
What the data says
Kura Oncology, Inc.'s operating income of -$304M is lower than 81% of companies in the Health Care sector (FY2025). Operating Income has declined for 3 consecutive years, from -$140M in FY2022 to -$304M in FY2025.
Based on SEC 10-K filings.
-$304M in FY2025.
Declined from -$166M to -$304M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 19% in Health CareTop 81% of 204This company -$303.6M Sector average $107.7M
▼
-381.9% below sector average
Key checks
Key Insights
- Kura Oncology, Inc.'s operating income has declined for 3 consecutive years.
- In FY2025, operating income decreased 57.2% year-over-year.
- Ranks #165 out of 204 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.83 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$303.6M | -57.2% |
| FY2024 | -$193.2M | -16.5% |
| FY2023 | -$165.8M | -18.5% |
| FY2022 | -$139.9M | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026